|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Boston Scientific Corporation (NYSE:BSX), a major manufacturer of interventional medical devices. |
|---|---|
| Transferring Party | Remon Medical Technologies Inc., an Israel based development-stage company focused on communication technology for medical device applications. |
| Sector | Medical Devices |
| Date | June 25, 2007 |
| Analysis Adds innovative sensor and wireless communication technology to BSX's cardiac rhythm management product line -- smart, miniature implants designed to enable physicians to assess and treat a variety of medical conditions in a non-invasive manner. Remon's technology monitorS a variety of physiological parameters, stimulateS tissues and organs or activateS other devices, creating therapeutic responses. Terms not disclosed. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |